Carboxypeptidase B1 in dialyzed chronic kidney disease patients
Abstract Carboxypeptidase B1 has long been known to be a pancreas-specific tissue enzyme. In this paper we focus on Carboxypeptidase B1 concentration measurement in dialyzed chronic kidney kidney disease patients and on the effect dialysis adequacy and regimen exert on its concentration. A total of...
Saved in:
| Main Authors: | Matej Stančík, Marián Grendár, Marián Mokáň |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-88332-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01) -
Renal organic anion transporter 1: clinical relevance and the underlying mechanisms in chronic kidney disease
by: Changfang You, et al.
Published: (2025-02-01) -
Comparison of uremic toxin removal between expanded hemodialysis and high volume online hemodiafiltrations in different modes
by: Jan Biedunkiewicz, et al.
Published: (2024-11-01) -
Fluorinated Zirconium‐Based Metal‐Organic Frameworks as Novel Sorbents to Improve the Efficacy of Hemodialysis Treatment
by: Fátima Guerrero, et al.
Published: (2025-07-01) -
Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01)